#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Prostate cancer Obesity Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Non-small cell lung cancer metastatic Dermatitis atopic Malignant melanoma Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Stargardt's disease Gastrointestinal disorder Rhabdomyosarcoma Gastrointestinal neuroendocrine tumour Necrotising enterocolitis neonatal Liver abscess Thrombocytosis Follicle centre lymphoma follicular grade I, II – III Hyperchylomicronaemia Systemic candida HER2 gene amplification Immunodeficiency congenital Ovarian epithelial cancer Chronic myelomonocytic leukaemia Warm autoimmune haemolytic anaemia More trials…

    Learn about Rare Diseases

    Angelman’s syndrome – Life with Disease Mucopolysaccharidosis II – Trials in Disease Mantle cell lymphoma stage IV – Trials in Disease Primary immunodeficiency syndrome – Diagnostics Testicular leiomyosarcoma – Diagnostics IgA nephropathy – Diagnostics Langerhans’ cell histiocytosis – Diagnostics Testicular leiomyosarcoma – Treatment Proteus syndrome – Treatment Congenital nephrogenic diabetes insipidus – Treatment More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Chlorambucil ALE.P02 Lidocaine Hydrochloride Amikacin Sulfate Pp1815 Melatonin Ubamatamab Mesenchymal Cells Oxcarbazepine Elezanumab Ngm707 Kk8123 Poltreg-T1D Hydroxi-Methionine Calcium Sodium Acetate Trihydrate RIVASTIGMINE Clavulanic Acid Aluminium Oxide Caplacizumab Dosulepin Hydrochloride More therapies…

    Learn about Your Condition

    Supranuclear palsy Tumour of ampulla of Vater Microvillous inclusion disease Pulmonary congestion Graft versus host disease Meningococcal infection Synovial sarcoma recurrent Low cardiac output syndrome Adenocarcinoma pancreas Peripheral spondyloarthritis B-cell lymphoma Pneumonia External cephalic version Infertility Cholangitis sclerosing More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of REGN7508 versus apixaban for treating and preventing cancer-associated blood clots in adults with solid or blood cancers

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    • Regn7508
    • Apixaban
    Bulgaria Romania

  • Study of Short‑and Long‑Term Hemodynamic and Physiological Effects of Mavacamten in Patients with Obstructive Hypertrophic Cardiomyopathy

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    • Mavacamten
    Sweden

  • Study of venetoclax plus rituximab in adult patients with relapsed chronic lymphocytic leukemia (CLL) in Poland

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Chronic lymphocytic leukaemia recurrent
    • Chronic lymphocytic leukaemia
    Investigated drugs:
    • Rituximab
    • Venetoclax
    Poland

  • Study of inhaled levodopa versus oral levodopa plus benserazide for early‑morning OFF in Parkinson’s disease patients

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Parkinson’s disease
    Investigated drugs:
    • Benserazide Hydrochloride
    • Levodopa
    Denmark

  • Safety, tolerability and exploratory efficacy of PST-611 in patients with geographic atrophy secondary to age-related macular degeneration

    Not yet recruiting

    2 1 1
    France

  • Evaluation of PIFLUFOLASTAT (18F) PET/CT for monitoring prostate cancer recurrence in patients with favourable intermediate‑risk localized disease after focal HIFU

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Prostate cancer
    France
Previous Page
1 … 656 657 658 659 660 … 1,616
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!